DiPaolo Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Sell
996
-171
-15% -$43.8K 0.15% 41
2026
Q2
$294K Sell
1,167
-59
-5% -$12.7K 0.19% 37
2026
Q1
$267K Buy
+1,226
New +$272K 0.19% 36

Other funds holding ABBV

DiPaolo Financial Group's ABBV Position: Q3 2026 in Review

DiPaolo Financial Group reduced its AbbVie (ABBV) stake by 15% in Q3 2026, selling an estimated $43.8K and leaving 996 shares worth $261K. The position accounts for 0.15% of the portfolio, ranked #41.

DiPaolo Financial Group first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $294K in Q2 2026. 4,280 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • DiPaolo Financial Group held 996 shares of AbbVie worth $261K as of Q3 2026.
  • DiPaolo Financial Group sold 171 AbbVie shares in Q3 2026, an estimated $43.8K.
  • AbbVie made up 0.15% of DiPaolo Financial Group's portfolio in Q3 2026, its #41 holding.
  • DiPaolo Financial Group first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • DiPaolo Financial Group's AbbVie position peaked at $294K in Q2 2026.
  • 4,280 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on DiPaolo Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.